Aspartic Acid Endopeptidases
"Aspartic Acid Endopeptidases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A sub-subclass of endopeptidases that depend on an ASPARTIC ACID residue for their activity.
| Descriptor ID |
D016282
|
| MeSH Number(s) |
D08.811.277.656.074.500 D08.811.277.656.300.048
|
| Concept/Terms |
Aspartic Acid Endopeptidases- Aspartic Acid Endopeptidases
- Acid Endopeptidases, Aspartic
- Endopeptidases, Aspartic Acid
- Aspartyl Endopeptidases
- Endopeptidases, Aspartyl
- Aspartic Endopeptidases
|
Below are MeSH descriptors whose meaning is more general than "Aspartic Acid Endopeptidases".
Below are MeSH descriptors whose meaning is more specific than "Aspartic Acid Endopeptidases".
This graph shows the total number of publications written about "Aspartic Acid Endopeptidases" by people in this website by year, and whether "Aspartic Acid Endopeptidases" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 3 | 4 | 7 |
| 1997 | 1 | 0 | 1 |
| 1998 | 2 | 2 | 4 |
| 1999 | 3 | 0 | 3 |
| 2000 | 4 | 1 | 5 |
| 2001 | 3 | 8 | 11 |
| 2002 | 4 | 8 | 12 |
| 2003 | 7 | 7 | 14 |
| 2004 | 3 | 10 | 13 |
| 2005 | 6 | 15 | 21 |
| 2006 | 6 | 6 | 12 |
| 2007 | 7 | 0 | 7 |
| 2008 | 4 | 3 | 7 |
| 2009 | 2 | 1 | 3 |
| 2010 | 3 | 2 | 5 |
| 2011 | 5 | 0 | 5 |
| 2012 | 6 | 6 | 12 |
| 2013 | 2 | 1 | 3 |
| 2014 | 4 | 1 | 5 |
| 2015 | 6 | 1 | 7 |
| 2016 | 4 | 3 | 7 |
| 2017 | 3 | 2 | 5 |
| 2018 | 5 | 1 | 6 |
| 2019 | 4 | 4 | 8 |
| 2020 | 4 | 1 | 5 |
| 2021 | 4 | 1 | 5 |
| 2022 | 1 | 2 | 3 |
| 2023 | 0 | 2 | 2 |
| 2024 | 1 | 1 | 2 |
| 2025 | 2 | 1 | 3 |
Below are the most recent publications written about "Aspartic Acid Endopeptidases" by people in Profiles.
-
Proteolytic processing and host nuclear targeting of the novel effector GRA84 in Toxoplasma gondii. Mol Biol Cell. 2025 Aug 01; 36(8):ar97.
-
Discovery of an APP-selective BACE1 inhibitor for Alzheimer's disease. Neurotherapeutics. 2025 Sep; 22(5):e00610.
-
Napsin-A Expression in Mesonephric and Mesonephric-like Adenocarcinomas: Implications for Distinction From Clear Cell Carcinoma. Int J Gynecol Pathol. 2025 Nov 01; 44(6):526-531.
-
Air pollution amyloidogenesis is attenuated by the gamma-secretase modulator GSM-15606. Alzheimers Dement. 2024 Sep; 20(9):6107-6114.
-
Impact of protein conformations on binding free energy calculations in the beta-secretase 1 system. J Comput Chem. 2024 Sep 05; 45(23):2024-2033.
-
Exercise training and BDNF injections alter amyloid precursor protein (APP) processing enzymes and improve cognition. J Appl Physiol (1985). 2023 07 01; 135(1):121-135.
-
Sex differences in the progression of glucose metabolism dysfunction in Alzheimer's disease. Exp Mol Med. 2023 05; 55(5):1023-1032.
-
Acute interleukin-6 modulates key enzymes involved in prefrontal cortex and hippocampal amyloid precursor protein processing. J Appl Physiol (1985). 2023 05 01; 134(5):1115-1123.
-
Overexpression of alpha synuclein disrupts APP and Endolysosomal axonal trafficking in a mouse model of synucleinopathy. Neurobiol Dis. 2023 03; 178:106010.
-
Voluntary wheel running alters markers of amyloid-beta precursor protein processing in an ovarian hormone depleted model. Front Endocrinol (Lausanne). 2022; 13:1069404.